Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€205.20

€205.20

-3.210%
-6.8
-3.210%
€315.54

€315.54

 
20.02.26 / Tradegate WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Latest predictions
€301.96
20.02.26
0.10%
buy
€292.49
19.02.26
-3.07%
buy
€305.21
19.02.26
-3.07%
buy
€254.34
19.02.26
-3.07%
buy
€288.25
19.02.26
-3.07%
buy
19.02.26
-3.98%
buy
Your prediction

Insulet Corp. Stock

Insulet Corp. took a tumble today and lost -€6.800 (-3.210%).
The stock is an absolute favorite of our community with 54 Buy predictions and no Sell predictions.
With a target price of 315 € there is a hugely positive potential of 53.51% for Insulet Corp. compared to the current price of 205.2 €.
So far the community has only identified positive things for Insulet Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Insulet Corp. in the next few years

Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Insulet Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Insulet Corp. -3.210% 0.391% -15.416% -25.273% -15.971% -26.346% -9.284%
Neogen Corp. 2.670% 6.630% 20.625% 0.521% 56.911% - -
Merit Medical Systems 0.000% 1.471% 0.000% -30.653% -6.757% 7.813% 41.975%
Bio-Rad Labs Inc. A -1.520% 6.948% -13.521% -15.328% -10.469% -48.632% -56.434%

Comments

Prediction Buy
Perf. (%) 0.10%
Target price 301.963
Change
Ends at 20.02.27

Insulet (NASDAQ:PODD) had its price target lowered by analysts at Raymond James Financial, Inc. from $385.00 to $355.00. They now have an "outperform" rating on the stock.
Ratings data for PODD provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -3.07%
Target price 292.491
Change
Ends at 19.02.27

Insulet (NASDAQ:PODD) had its price target lowered by analysts at Citigroup Inc. from $380.00 to $345.00. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -3.07%
Target price 305.208
Change
Ends at 19.02.27

Insulet (NASDAQ:PODD) was given a new $360.00 price target on by analysts at Truist Financial Corporation. They now have a "buy" rating on the stock.
Ratings data for PODD provided by MarketBeat
Show more

News

Is Insulet (PODD) the Future of Diabetes Management?: https://g.foolcdn.com/editorial/images/851028/mqdefault-68.jpg
Is Insulet (PODD) the Future of Diabetes Management?

Explore the exciting world of Insulet (NASDAQ: PODD) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market